Login

Severn Trent CEO Liv Garfield addressing investors at the Hardman & Co Investor Forum. 00:10:00

Share On Facebook Share On Twitter

Kun-Tsung Huang is President at Shin Shin Natural Gas Co Ltd.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Driving Total Shareholder Returns: Navigating the Mining Sector's Role in the Energy Transition and ESG Imperatives|Olivia Markham,Portfolio Manager, BlackRock2
00:10:00
Jacob George: Insights from an Investment Advising Expert - Jacob George | Investment Advisor | Core Planning
00:10:00
AI researchers investing in AI deeptech and the future of work|Josh Albrecht,General Partner,Outset Capital
00:10:00
G3 Exploration to Spin Out China Gas Assets via Green Dragon Gas in Landmark Move
00:10:00
Plateau Energy Metals CEO Highlights Large-Scale Lithium and Uranium Projects in Peru
00:10:00
Erez Raphael Envisions Future of Digital Therapeutics Post Livongo Acquisition | Erez Raphael , Chief Executive Officer of Dariohealth Corp.
00:10:00
Empowering Financial Futures: A Personal Journey in Financial Advising
00:10:00
CEO Discusses Future Dividend, Domestic Focus, and Industry Impact of Competitor | Erik Selin, CEO, Fastighets AB Balder.
00:10:00
Critical Resources (ASX: CRR) Twilight Series Review (September 2023) | Alex Cheeseman, Managing Director of Critical Resources Limited
00:10:00
Gaurav Mehta Shares Quarterly Updates on SBI ESG PMS| Gaurav Mehta , CIO , SBI Mutual Fund .
00:10:00
Empowering Europe's Future: Mina do Barroso Lithium Project
00:10:00
CEO Alain Moussy Expounds on the Complex Journey of Masitinib Development in Interview| Alain Moussy, CEO, AB Science SA.

© 2017 - Neuhu+